Tuesday, 8 January 2019

METABOLIC DISEASES MEET 2019

About Conference

                                                    

 ME Conference has the enormous pleasure in organising “INTERNATIONAL CONFERENCE ON METABOLIC DISEASES AND LIVER CANCER ’’ during 27-28 of May in Istanbul, Turkey. This conference is an exposed platform for Researchers, Aspiring students, Directors, Professors, Scientists, Academicians and Young researchers of life science department to present their diligent work in front of prominent personalities of the same field. The thoughts and work of the scholastic individuals can be presented in the shape of verbal presentations, poster presentations and video presentations who are interested to gain global appreciation and to add progression to human lives from their work. This conference offers wider knowledge in liver cancer and metabolic diseases thereby providing futuristic approaches to treat them in the near future.

Why to attend?

                                        “THE ONLY SOURCE OF KNOWLEDGE IS EXPERIENCE”

“INTERNATIONAL CONFERENCE ON METABOLIC DISEASES AND LIVER CANCER ’’ is organized in order to bring light and anticipate to the dark sides of human liver cancer and irregular human metabolic diseases which are prevailing worldwide. This conference is effective on all sides as it gives exposure in an international way for people who attend and experience for people who present their work in front of people expertized in the area of Hepatology and Human metabolism.

Target Audience
  • Anaesthesiologist
  • Clinical Research Associates
  • Diabetes Educators
  • Dieticians
  • Genetic Counsellor
  • Healthcare Professionals
  • Industrialists
  • Medical Oncologists
  • Metabolic Professionals
  • Medicinal Professionals
  • Nutritionists
  • Pharmacologists
  • Professors
  • Radiation Oncologists
  • Research, Healthcare Scientists
  • Surgical Oncologists

Conference Highlights



Special Issues


  •  All accepted abstracts will be published in respective Supporting International Journals.
  •  Abstracts will be provided with Digital Object Identifier by Cross Ref.